Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Samantha O. Hasenleithner

Medical University of Graz

Austria

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Cell Biology

50%

Biostatistics

70%

Cancer Biology

80%

Liquid Biopsy

40%

Cancer Therapy

40%

Next-generation Sequencing

30%

Dna Damage

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles12

Clinical applications of next‐generation sequencing‐based <scp>ctDNA</scp> analyses in breast cancer: defining treatment targets and dynamic changes during disease progression

Article Link

Year:

2024

Liquid profiling for patients with advanced cancer is ready for clinical integration

Article Link

Year:

2024

Accelerating the Development and Validation of Liquid Biopsy for Early Cancer Screening and Treatment Tailoring

Article Link

Year:

2022

How to detect cancer early using cell-free DNA.

Article Link

Year:

2022

A clinician's handbook for using ctDNA throughout the patient journey.

Article Link

Year:

2022

Dynamic Changes of Circulating Tumor DNA Predict Clinical Outcome in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors.

Article Link

Year:

2021

Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.

Article Link

Year:

2021

Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer

Article Link

Year:

2020

Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors

Article Link

Year:

2020

Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection

Article Link

Year:

2020

On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancer.

Article Link

Year:

2020

Comparison of three commercial decision support platforms for matching of next-generation sequencing results with therapies in patients with cancer.

Article Link

Year:

2020

Collaborators6

Catherine Alix-Panabières

Associate Professor, Director

University Hospital of Montpellier

FRANCE

Ellen Heitzer

Full Professor

Medical University of Graz

AUSTRIA

Gerald Hoefler

Professor for Pathology

Medical University of Graz

AUSTRIA

Francesco Gatto

Karolinska Institutet

SWEDEN

Sinead Toomey

Royal College of Surgeons in Ireland

IRELAND

Michael R Speicher

Medical University of Graz

AUSTRIA

How do I reach out?

Meet Kite AI